ArticleThe Journal of pharmacology and experimental therapeutics2021

Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension.

Yasir AlSiraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.